UPDATE | August 4, 2022

Achieving Faster Investigational New Drug Timelines with a Robust Cell Line Development Strategy

  • MAIL

MEDIA FOCUS 

MEDIA FOCUS

Achieving Faster Investigational New Drug Timelines with a Robust Cell Line Development Strategy

Youlim Kim

Lead Scientist, Cell Line Development

 

Technological advances in drug manufacturing equipment and process optimization play a significant role in increasing speed to market of critical biologic drugs. In this article, Youlim Kim, our Lead Scientist in Cell Line Development, explores the challenges associated with CLD and offers an expert look into the tactics CDMOs can employ to shorten commercial timelines while preserving quality and yield. 

 

Learn more (See page 44-45) 

 

 

MEDIA FOCUS 

MEDIA FOCUS

Achieving Faster Investigational New Drug Timelines with a Robust Cell Line Development Strategy

Youlim Kim

Lead Scientist, Cell Line Development

 

Technological advances in drug manufacturing equipment and process optimization play a significant role in increasing speed to market of critical biologic drugs. In this article, Youlim Kim, our Lead Scientist in Cell Line Development, explores the challenges associated with CLD and offers an expert look into the tactics CDMOs can employ to shorten commercial timelines while preserving quality and yield. 

 

Learn more (See page 44-45) 

 

 

  • CDO
  • CGMP
  • ADC
  • Bio Campus
  • IR
  • CMO

Share article

  • MAIL

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Interests
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy required